Concepedia

Author

Signe Friesland

Karolinska University HospitalORCID

Also Known As

S Friesland, S. Friesland, SIGNE FRIESLAND, Signe Friesland, Signe Friesland, Magnus G. Lind, Ja

106

Publications

5.8K

Citations

29

H-Index

59

Concepts

All Affiliations

Karolinska University HospitalKarolinska InstitutetSahlgrenska University HospitalUmeå UniversitySophiahemmet Hospital
SF

About

Signe Friesland is an author at Karolinska University Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

30

3.6K

2

Health Sciences

16

18

1.3K

3

Gastroenterology

6

6

602

4

Business

1

1

24

5

Engineering

1

1

24

Signe Friesland

×

52

Publications

5.6K

Citations

28

H-Index

YearCitations

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau,

The Lancet

2018

1.6K

Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

Pia Baumann, Jan Nyman, Berit Wennberg,

Journal of Clinical Oncology

2009

838

A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction

Fredrik Klevebro, Gabriella Alexandersson von Döbeln, N. Wang,

Annals of Oncology

2016

389

Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival

Hanna Mellin, Signe Friesland, Rolf Lewensohn,

International Journal of Cancer

2000

373

SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC

Jan Nyman, Andreas Hallqvist, Jo-Åsmund Lund,

Radiotherapy and Oncology

2016

339

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries

Pia Baumann, Jan Nyman, Ingmar Lax,

Acta Oncologica

2006

224

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial

Gabriella Alexandersson von Döbeln, Fredrik Klevebro, A-B Jacobsen,

Diseases of the Esophagus

2018

162

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer

Maria Gebre‐Medhin, Eva Brun, Per Engström,

Journal of Clinical Oncology

2020

158

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

Pia Baumann, Jan Nyman, Giovanna Gagliardi,

Radiotherapy and Oncology

2008

139

Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation

Fredrik Klevebro, Gjermund Johnsen, Eugene H. Johnson,

European Journal of Surgical Oncology

2015

104

Page 1